Budget vs premium
MedVi vs SnagRx: Which Costs Less Over 12 Months? (2026)
MedVi $299/mo vs SnagRx $99/mo. 2026 comparison of pricing, medication and support, with 12-month totals rather than first-month offers.
Published · Pricing as published in our provider dataset, synced · Editorial scores 9.0 and 7.5 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
On paper, MedVi and SnagRx sell the same thing: a prescription, a vial and a delivery date. In practice they are priced and staffed on different assumptions.
On the number that matters after the first month, they are not close: SnagRx runs $99/mo against $299/mo at MedVi — 3.0x more, every month, for the same drug class.
Rather than restate two feature lists, this compares the two on cost over time, medication access, price stability and the support each one includes. Where a provider quotes only after intake, that is recorded as the answer rather than replaced with a guess.
The short answer
- Lowest 12-month cost
- SnagRx — $828 against $2,592 at MedVi, on each provider's own best published pricing.
- Most predictable bill
- SnagRx — Flat rate at every dose, so titration does not change what you are charged.
- Tirzepatide access
- SnagRx — Tirzepatide at $149/mo; the other side publishes semaglutide only.
- Longest public track record
- MedVi — 12,896 patient reviews against 9,860.
MedVi and SnagRx, side by side
Two programs, side by side, on their own published terms — with the rows that differ doing the work.
| MedVi | SnagRx | |
|---|---|---|
| Advertised price | $179 promotional first month | Semaglutide $99/mo month-to-month, or $69/mo on the 12-month plan |
| Rate after promotions | $299/mo | $99/mo |
| Pricing structure | Promotional first month, then standard rate | Flat rate at every dose |
| Medication | Compounded semaglutide | Compounded semaglutide and compounded tirzepatide |
| Membership fee | None | None |
| Payment options | Card only, no financing published | Card only, no financing published |
| State coverage | Not published | 48 states |
| How fast you start | Simple online process, no clinic visits | 5-minute intake, clinician review typically within 5 hours and always within 24 |
| Patient reviews | 12,896 | 9,860 |
| eRxDoctor score | 9.0/10 | 7.5/10 |
The real cost: six months and twelve
A first-month price is a customer-acquisition number. The totals below are the honest version, built from the rates each provider publishes.
| MedVi | SnagRx | |
|---|---|---|
| First month | $179 | $99 |
| Months 2 onward | $299/mo | $99/mo |
| 6-month total | $1,674 | $594 |
| 12-month total | $3,468 | $1,188 |
| Best published plan | 3-month plan at $649 — $2,592/yr | 12-month semaglutide plan at $69/mo ($828 a year) — $828/yr |
Over a year that is a $1,764 difference, in SnagRx's favor. Whether it is the right call depends on whether MedVi gives you $147 a month of something you will use.
Price escalation to plan for: MedVi moves from $179 to $299, a 67% increase. Set a calendar reminder for the month it changes.
SnagRx is cheaper. Does that make it better?
The gap runs to 3.0x a month. What MedVi offers for it: 24/7 support from certified medical professionals, plus fast, free shipping.
SnagRx counters with the rate is locked at every dose for the life of treatment, and the four US 503A partner pharmacies and the prescribing clinician network are both named publicly, and the thing it asks you to accept in return: the advertised $69 and $119 rates require the 12-month plan — month-to-month is $99 and $149.
For a patient who has taken a GLP-1 before, knows how they titrate and needs a reliable monthly refill, the cheaper program is usually the correct one and the premium is a donation. For a first prescription, the calculus changes.
How MedVi works
MedVi provides compounded semaglutide starting at $179/month with a simple online intake, no clinic visits, and 24/7 certified medical support for weight loss.
Intake is simple online process, no clinic visits. Fulfillment is fast, free shipping. The commercial terms are promotional first month, then standard rate, published upfront.
Support: 24/7 support from certified medical professionals. The medications on offer are compounded semaglutide.
MedVi pros
- Simple online process with no clinic visits required
- 24/7 support from certified medical professionals
- Clinically dosed compounded semaglutide
- Low promotional first month at $179 including fast, free shipping
MedVi cons
- Compounded medication only, no branded Ozempic or Wegovy
- No published outcome or weight loss guarantee
- Price increases sharply after the first month, $299 for a standalone month
Set beside SnagRx, the thing to weigh: the price roughly doubles to $299 once the promotional month ends.
SnagRx: what you are buying
The pitch is the rate is locked at every dose for the life of treatment, and the four US 503A partner pharmacies and the prescribing clinician network are both named publicly. SnagRx offers compounded semaglutide from $69/month and tirzepatide from $119/month, with the rate locked flat at every dose, named US 503A pharmacies and next-day shipping.
Getting started means 5-minute intake, clinician review typically within 5 hours and always within 24, after which free next-day UPS or FedEx in temperature-controlled packaging. Pricing runs on a flat rate at every dose basis, published upfront.
1:1 nursing staff plus a secure patient portal for refills and dose changes. The formulary covers compounded semaglutide and compounded tirzepatide.
SnagRx pros
- Names its four US 503A partner pharmacies and its clinician network (OpenLoop Health)
- States LegitScript certification, which patients can verify independently
- Bottom-of-market pricing on the annual plan: $69/mo semaglutide, $119/mo tirzepatide
- Price locked flat at every dose and at renewal — no re-pricing during titration
SnagRx cons
- Heavy urgency marketing, including a countdown timer on the pricing page
- No coaching or nutrition programming of any kind
- Compounded medication only, no branded Ozempic, Wegovy, Mounjaro, or Zepbound
Against MedVi specifically, the trade you are making: the advertised $69 and $119 rates require the 12-month plan — month-to-month is $99 and $149.
MedVi or SnagRx: matching the program to the patient
Choose MedVi if:
- delivery works the way you want it to: fast, free shipping
- you are willing to commit for a term in exchange for a lower effective rate (3-month plan at $649)
- you would get real value from a genuinely low promotional entry point with 24/7 clinical support behind it
- the level of clinical contact suits you: 24/7 support from certified medical professionals
Choose SnagRx if:
- the twelve-month total is what you are optimizing ($1,188 against $3,468)
- you would get real value from the rate is locked at every dose for the life of treatment, and the four US 503A partner pharmacies and the prescribing clinician network are both named publicly
- the level of clinical contact suits you: 1:1 nursing staff plus a secure patient portal for refills and dose changes
- you want to start on their timeline: 5-minute intake, clinician review typically within 5 hours and always within 24
Where each program concedes something
On price. SnagRx is the cheaper program at $99/mo against $299/mo. What SnagRx gives up for that is the advertised $69 and $119 rates require the 12-month plan — month-to-month is $99 and $149; what MedVi charges for is a genuinely low promotional entry point with 24/7 clinical support behind it.
On commitment. MedVi rewards a longer commitment (3-month plan at $649), which lowers the effective rate but ties up money before you know how you respond to the medication. Neither publishes financing options, so plan for the full amount each month.
On medication. MedVi covers compounded semaglutide; SnagRx covers compounded semaglutide and compounded tirzepatide. Only SnagRx publishes a tirzepatide route, which matters if semaglutide underdelivers.
On clinical contact. MedVi provides 24/7 support from certified medical professionals. SnagRx provides 1:1 nursing staff plus a secure patient portal for refills and dose changes. Both are asynchronous-first services and neither replaces a physician who can examine you.
What the trials and the FDA say
The efficacy data people cite when comparing these platforms is not platform data. It comes from trials of the underlying medication, and it applies to both.
The STEP 1 extension found participants regained roughly two-thirds of the weight they had lost within a year of stopping semaglutide, per Diabetes, Obesity and Metabolism.
SURMOUNT-1 put tirzepatide at roughly a 21% mean body-weight reduction at its highest dose over 72 weeks, per NEJM, SURMOUNT-1.
None of that settles which of these two to use. It does mean the drug is doing the work, and you are choosing who supplies it and on what terms.
MedVi vs SnagRx: common questions
Does the price go up as my dose increases?
At SnagRx, no — the rate is locked at every dose for the life of treatment, and the four US 503A partner pharmacies and the prescribing clinician network are both named publicly. At MedVi, the published structure is promotional first month, then standard rate, moving from $179 to $299. Since GLP-1 doses escalate over the first months, that difference is worth more than most feature comparisons.
Which is cheaper to start, MedVi or SnagRx?
SnagRx, at $99 against $179. Note that the cheapest first month and the cheapest year are often different providers here — check the 12-month row of the cost table before deciding on the entry price.
Are MedVi and SnagRx legitimate?
Both are licensed telehealth platforms that route a prescription through a clinician review before anything is dispensed; neither sells medication without one. MedVi operates on promotional first month, then standard rate with pricing published upfront, SnagRx on flat rate at every dose, published upfront. The meaningful due diligence is on the medication category and the terms, not on whether the platforms are real.
What happens if I stop taking the medication?
Neither MedVi nor SnagRx penalizes you for stopping, but the medication does. The published follow-up data on withdrawal shows substantial regain, which is why the twelve-month totals above matter more than either provider's introductory offer.
Is MedVi or SnagRx better for a first GLP-1 prescription?
For a first prescription, weight support over price. MedVi offers more contact (24/7 support from certified medical professionals), which matters most in the first eight weeks when side effects and titration questions are at their peak. Once you know how you tolerate the medication, the cheaper program becomes the rational choice.
The verdict
On the numbers, SnagRx wins the year: $828 against $2,592. That is the default answer, and it is the right one for anyone who mainly needs a reliable prescription and a shipment that arrives.
Where MedVi justifies itself is a genuinely low promotional entry point with 24/7 clinical support behind it. Where it does not is anywhere the extra spend buys features you will never open.
Get the maintenance-dose price in writing from whichever one you pick. That single question prevents most of the regret in this category.
Keep comparing
- MedVi vs DirectmedsPublished price vs quote-only
- MedVi vs MeasuredBudget vs premium
- Yucca Health vs SnagRxBudget vs premium
- TrimRx vs SnagRxBudget vs premium
- Enhance MD vs Start WillowBudget vs premium
- Enhance MD vs He & She MDBudget vs premium
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by MedVi or SnagRx, and does not sell treatment. Read our ranking methodology.